down arrow

Fortis Malar

  • Market Cap: Micro Cap
  • Industry: Hospital & Healthcare Services
  • ISIN: INE842B01015
  • NSEID:
  • BSEID: 523696
INR
84.80
0.22 (0.26%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 65.81 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

81.0089.00

52 Week

51.01107.94
Valuation
Technical
Day's Volume

CASH

65.81 k (-40.23%) Volume

Shareholding (Dec 2024)

FII

0.00%

Held by 0 FIIs

DII

0.07%

Held by 0 DIIs

Promoter

62.71%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

  • Poor long term growth as Net Sales has grown by an annual rate of -46.41% over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -2.04
2

Flat results in Dec 24

3

Risky - Negative EBITDA

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Hospital & Healthcare Services

stock-summary
Market cap

INR 159 Cr (Micro Cap)

stock-summary
P/E

159.00

stock-summary
Industry P/E

55

stock-summary
Dividend Yield

50.25%

stock-summary
Debt Equity

-1.13

stock-summary
Return on Equity

-10.87%

stock-summary
Price to Book

5.31

Revenue and Profits (1 Year):
Net Sales:
(Quarterly Results - Dec 2024)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (50.25%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
47.5%
0%
47.5%
1 Year
51.67%
2.80%
54.47%
2 Years
73.03%
84.48%
157.51%
3 Years
39.13%
78.70%
117.83%
4 Years
38.9%
66.77%
105.67%
5 Years
88.86%
95.51%
184.37%

Latest dividend: 2.5 per share ex-dividend date: Jul-24-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-46.41%
EBIT Growth (5y)
12.69%
EBIT to Interest (avg)
-2.04
Debt to EBITDA (avg)
9.63
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.65
Tax Ratio
8.17%
Dividend Payout Ratio
175.88%
Pledged Shares
0
Institutional Holding
0.07%
ROCE (avg)
-79.22%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
159
Industry P/E
55
Price to Book Value
5.31
EV to EBIT
-53.05
EV to EBITDA
-96.63
EV to Capital Employed
-31.01
EV to Sales
22.58
PEG Ratio
1.51
Dividend Yield
50.25%
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-10.87%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 1 Schemes (0.07%)

FIIs

Held by 0 FIIs

Promoter with highest holding

Fortis Hospitals Limited (62.71%)

Highest Public shareholder

Ruckmani Natarajan (2.07%)

Individual Investors Holdings

29.43%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 0.00% vs 0.00% in Sep 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -88.89% vs 250.00% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.41",
          "val2": "-0.47",
          "chgp": "12.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.01",
          "val2": "0.09",
          "chgp": "-88.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -100.00% vs -17.24% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 100.42% vs 35.69% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "35.91",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.36",
          "val2": "-0.60",
          "chgp": "-126.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.01",
          "val2": "2.65",
          "chgp": "-99.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.02",
          "val2": "-4.72",
          "chgp": "100.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "-1.67%",
          "chgp": "1.67%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -100.00% vs -18.07% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 100.34% vs -2.71% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "53.49",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.77",
          "val2": "-1.69",
          "chgp": "-4.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.01",
          "val2": "3.91",
          "chgp": "-99.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.03",
          "val2": "-8.72",
          "chgp": "100.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "-3.16%",
          "chgp": "3.16%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is -31.34% vs -0.27% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 392.76% vs -87.18% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "59.01",
          "val2": "85.95",
          "chgp": "-31.34%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.20",
          "val2": "4.57",
          "chgp": "-126.26%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "4.30",
          "val2": "6.07",
          "chgp": "-29.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "57.93",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "45.32",
          "val2": "-15.48",
          "chgp": "392.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2.03%",
          "val2": "5.32%",
          "chgp": "-7.35%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.41
-0.47
12.77%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.01
0.09
-88.89%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
Values in Rs Cr.
stock-summary Compare with Peers
Net Sales

QoQ Growth in quarter ended Dec 2024 is 0.00% vs 0.00% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is -88.89% vs 250.00% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
0.00
35.91
-100.00%
Operating Profit (PBDIT) excl Other Income
-1.36
-0.60
-126.67%
Interest
0.01
2.65
-99.62%
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.02
-4.72
100.42%
Operating Profit Margin (Excl OI)
0.00%
-1.67%
1.67%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -100.00% vs -17.24% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 100.42% vs 35.69% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
0.00
53.49
-100.00%
Operating Profit (PBDIT) excl Other Income
-1.77
-1.69
-4.73%
Interest
0.01
3.91
-99.74%
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.03
-8.72
100.34%
Operating Profit Margin (Excl OI)
0.00%
-3.16%
3.16%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -100.00% vs -18.07% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 100.34% vs -2.71% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
59.01
85.95
-31.34%
Operating Profit (PBDIT) excl Other Income
-1.20
4.57
-126.26%
Interest
4.30
6.07
-29.16%
Exceptional Items
57.93
0.00
Consolidate Net Profit
45.32
-15.48
392.76%
Operating Profit Margin (Excl OI)
-2.03%
5.32%
-7.35%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is -31.34% vs -0.27% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 392.76% vs -87.18% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Fortis Malar Hospitals Ltd stock-summary
stock-summary
Fortis Malar Hospitals Ltd
Micro Cap
Hospital & Healthcare Services
Fortis Malar Hospital Limited (formerly known as Malar Hospital Limited) was established on April 13, 1989 to set up, manage and operate a multi-specialty hospital. The Company was changed to 'Fortis Malar Hospital Limited' on December 21, 2010. The Hospital was acquired by Fortis Group in early 2008. The hospital founded in 1989, has established itself as one of the largest corporate hospitals in Chennai, providing quality super specialty and multi-speciality healthcare services.
Company Coordinates stock-summary
Company Details
Fortis Hospital Sector-62, Phase-VIII Mohali Punjab : 160062
stock-summary
Tel: +91-172-5096001
stock-summary
http://www.fortismalar.com
stock-summary
secretarial.malar@malarhospitals.in
Registrar Details
Karvy Computershare Pvt Ltd, Plot No 17-24 , Near Image Hospital,, Reliance Cybervilae,Vithalrao Nagar,, Madhapur, Hyderabad
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."